The Times of India
India News: HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and licencing agreements with Chin.
Read More
Dr Reddy’s inks South East Asia commercialisation, licence pacts with China’s Bio-Thera for Stelara, Simponi biosimilars
TNN
20:21
India News: HYDERABAD: Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and licencing agreements with Chin.
